Drug Shortage Report for GABAPENTIN
| Report ID | 69781 |
| Drug Identification Number | 02388200 |
| Brand name | GABAPENTIN |
| Common or Proper name | GABAPENTIN |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 600MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2019-01-28 |
| Actual start date | 2019-01-28 |
| Estimated end date | 2019-05-10 |
| Actual end date | 2019-05-10 |
| Shortage status | Resolved |
| Updated date | 2019-05-13 |
| Company comments | Temporarily unavailable |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-12-17 | English | Compare |